• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of cerebral amine metabolism in mood disorders and anxiety disorders by positron emission tomography.

Research Project

Project/Area Number 09670974
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Psychiatric science
Research InstitutionGunma University School of Medicine

Principal Investigator

IDA Itsurou  Gunma University School of Medicine, Department of Neuropsychiatry, Lecturer, 医学部・神経精神医学講座, 講師 (50251103)

Co-Investigator(Kenkyū-buntansha) TOMOYOSHI Katsumi  Gunma University School of Medicine, Department of Nuclear Medicine and Diagnost, 医学部・核医学講座, 助手 (60188802)
MIKUNI Masahiko  Gunma University School of Medicine, Department of Neuropsychiatry, Professor, 医学部・神経精神医学講座, 教授 (90060508)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1998: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1997: ¥2,300,000 (Direct Cost: ¥2,300,000)
KeywordsMood Disorder / Anxiety Disorder / Positron emission tomography / catecholamine / Glucose metabolism / 感情障害
Research Abstract

We conducted the measurement of catecholamine metabolism in patients Buffered with mood disorder with PET using anewly synthesized [18F]fluoro- alpha -methyl-L-tyrosine (18F-FAmT), a radioactive tyrosine analogue, as suitable PET tracer forobservation of catecholamine synthesis in living brain. However, no significant difference was observed in 18F-FAmT uptakevalue between patients and controls. We also examined the function of hypothalamic-pituitary-adrenal axis (HPA) indepressed patients using combined dexamethasone (DEX)/corticotropin-releasing hormone (CRH) test. Approximately 70 %of patients in acute depressive episode were determined as non-suppressors with higher plasma cortisol than controls (morethan 5 mu g/dl after CRH administration). Moreover, 6 non-suppressors showed significant lower glucose metabolism inhippocampal region (p<0.05) as compared with sex and age-matched healthy controls. These results suggest the relationshipbetween the HPA dysfunction and abnormal hippocampal glucose metabolism in mood disorders.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report

Research Products

(3 results)

All Other

All Publications (3 results)

  • [Publications] Tomio Inoue, et al.: "F-18 -methyl-tyrosine PET studies in patients with brain tumors." J.Nuclear Medicine. 40・3. 399-405 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tomio Inoue: "F-18 alpha-methyl-tyrosine PET studies in patients with brain tumors." J Nucl.Med.40. 399-405 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tomio Inoue, et al.: "F-18 α-methyl tyrosine PET studies in patients with brain tumors." J. Nuclear Medicine. in press.

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1997-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi